Dennis Mulroy - 14 Sep 2022 Form 4 Insider Report for ANAPTYSBIO, INC (ANAB)

Role
Chief Financial Officer
Signature
/s/ Eric Loumeau, Attorney-in-Fact
Issuer symbol
ANAB
Transactions as of
14 Sep 2022
Net transactions value
$0
Form type
4
Filing time
16 Sep 2022, 17:06:58 UTC
Previous filing
27 Jun 2022
Next filing
10 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANAB Restricted Stock Unit Award $0 +12,000 $0.000000 12,000 14 Sep 2022 Common Stock 12,000 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a one-time retention grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
F2 50% of the total RSUs vest on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F3 In addition to the remaining options to purchase 12,000 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 215,600 shares of common stock, which options vest according to their terms, and (ii) 964 shares of common stock held directly.